"Isoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies from an individual that react with ISOANTIGENS of another individual of the same species.
| Descriptor ID |
D007518
|
| MeSH Number(s) |
D12.776.124.486.485.114.664 D12.776.124.790.651.114.664 D12.776.377.715.548.114.664
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Isoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Isoantibodies".
This graph shows the total number of publications written about "Isoantibodies" by people in this website by year, and whether "Isoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 5 | 1 | 6 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 0 | 4 |
| 2018 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Isoantibodies" by people in Profiles.
-
Long-Term Outcomes of Renal Transplant Allografts With De Novo DSA in the Setting of Stable Function. Clin Transplant. 2026 May; 40(5):e70576.
-
RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report. Am J Hematol. 2026 Apr; 101(4):756-767.
-
Potential synergistic role of pre-formed GSTT1 antibodies and de novo HLA antibodies in a heart-transplant recipient diagnosed with AMR. Hum Immunol. 2026 Feb; 87(2):111648.
-
Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates. Clin Transplant. 2024 02; 38(2):e15249.
-
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect. Blood. 2023 09 14; 142(11):1008-1021.
-
Reducing number of laboratories performing complement dependent cytotoxicity crossmatching: Reasons and conclusions. Hum Immunol. 2022 May; 83(5):467-475.
-
HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors. Mayo Clin Proc. 2021 10; 96(10):2727-2728.
-
Long-Term Follow-Up of Renal Transplant Recipients Treated With IVIG for De Novo Donor-Specific Antibodies. Transplant Proc. 2021 Jul-Aug; 53(6):1865-1871.
-
The shared epitope phenomenon-A potential impediment to virtual crossmatch accuracy. Clin Transplant. 2020 08; 34(8):e13906.
-
Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease. Br J Haematol. 2020 04; 189(1):162-170.